BioMark Diagnostics, Inc. (BUX.CX)
0.50
+0.02
(+5.26%)
CAD |
CNSX |
Dec 08, 16:00
BioMark Diagnostics Total Liabilities (Quarterly): 1.014M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Justera Health Ltd. | 5.295M |
| Neural Therapeutics, Inc. | -- |
| ARCpoint, Inc. | 14.90M |
| Biocure Technology, Inc. | 0.4131M |
| Core One Labs, Inc. | -- |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.878M |
| Shareholders Equity (Quarterly) | 0.8635M |
| Debt to Equity Ratio | 0.1774 |
| Current Ratio | 1.732 |
| Net Debt Paydown Yield | 0.32% |